Document Detail


Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets.
MedLine Citation:
PMID:  20843569     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Enhanced external counterpulsation (EECP) is associated with improvement in endothelial function, angina and quality of life in patients with symptomatic coronary artery disease, although the mechanisms underlying the observed clinical benefits are not completely clear. The purpose of this study was to examine the effects of EECP on circulating haematopoietic progenitor cells (HPCs) and endothelial progenitor cells (EPCs) in patients with refractory angina. We compared HPC and EPC counts between patients scheduled for EECP and patients with normal angiographic coronary arteries, with and without coronary endothelial dysfunction. We hypothesized that an increase in circulating bone marrow derived progenitor cells in response to EECP may be part of the mechanism of action of EECP.
METHODS: Thirteen consecutive patients scheduled to receive EECP treatment were prospectively enrolled. Clinical characteristics were recorded and venous blood (5 ml) was drawn on day 1, day 17, day 35 (final session) and one month post completion of EECP therapy. Buffy coat was extracted and HPCs and EPCs were counted by flow cytometry.
RESULTS: Median Canadian Cardiovascular Society (CCS) angina class decreased and Duke Activity Status Index (DASI) functional score increased significantly (both, p < 0.05) in response to EECP, an effect that was maintained at one month after termination of treatment. Flow cytometric analysis revealed an accompanying significant increase in CD34+, CD133+ and CD34+, CD133+ CPC counts over the course of treatment (p < 0.05). DASI scores correlated significantly with CD34+ (R = 0.38 p = 0.02), CD133+ (R = 0.5, p = 0.006) and CD34+, CD133+ (R = 0.47, p = 0.01) CPC counts.
CONCLUSION: This study shows that HPCs, but not EPCs are significantly increased in response to EECP treatment and correlate with reproducible measures of clinical improvement. These findings are the first to link the functional improvement observed with EECP treatment with increased circulating progenitor cells.
Authors:
T J Kiernan; B A Boilson; L Tesmer; A Harbuzariu; R D Simari; G W Barsness
Related Documents :
20675909 - Examination of aggregation of various red blood cell populations can be informative in ...
11878779 - Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: decision analy...
16118499 - Short- and long-term outcomes of spontaneous csf hypovolemia.
24715769 - New synonymy of proceratium williamsi tiwari (hymenoptera, formicidae).
22923269 - Laser and led phototherapies on angiogenesis.
23429629 - Evaluation of trabectome in open-angle glaucoma.
9584249 - Astigmatism induced by intrastromal corneal suture after small incision phacoemulsifica...
24440439 - Long-term pt-inr levels and the clinical events in the patients with non-valvular atria...
22760389 - Long-term outcomes after arthroscopic capsular release for idiopathic adhesive capsulitis.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural     Date:  2010-09-16
Journal Detail:
Title:  International journal of cardiology     Volume:  153     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-21     Completed Date:  2012-08-16     Revised Date:  2014-09-18    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  202-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Antigens, CD34 / biosynthesis*,  blood
Cohort Studies
Counterpulsation / methods*
Endothelium, Vascular / cytology,  metabolism,  pathology
Flow Cytometry / methods
Hematopoietic Stem Cells / metabolism
Humans
Male
Middle Aged
Prospective Studies
Stem Cells / metabolism*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
HL75566/HL/NHLBI NIH HHS; R01 HL075566/HL/NHLBI NIH HHS; R01 HL075566-04/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD34
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoin...
Next Document:  Global longitudinal speckle-tracking strain is predictive of left ventricular remodeling after coron...